Somlo, George <br/><br/>
Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2013 
 - 1884-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-0652  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Biomarkers--blood<br/>Breast Neoplasms--blood<br/>Capecitabine<br/>Dasatinib<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Staging<br/>Pyrimidines--administration & dosage<br/>Thiazoles--administration & dosage<br/>Treatment Outcome